Editorial;Vitien II: Aortenklappenstenose

Herz

Volumn 31, Issue 7, 2006, Pages 617-619

  Erbel, Raimund ^a   Sack, Stefan ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE STENOSIS; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; ECHOCARDIOGRAPHY; EDITORIAL; HEMODYNAMICS; HUMAN; PATHOGENESIS; PREVALENCE; RISK FACTOR; SURGICAL TECHNIQUE;

ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33750539327     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-006-2908-5     Document Type: Editorial

References (25)

1. Kaden JJ. Pathogenese der kalzifizierenden Aortenklappenstenose. Herz 2006;31:620-28.
2. Schmermund A, Möhlenkamp S, Stang A, et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarcation and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 2002;144:212-8.
3. Koos R, Brandenburg V, Ketteler M, et al. Prävalenz und Pathogenese von Aortenklappenkalzifikationen. Herz 2006;31:629-34.
4. Anger T, Ekici AB, Daniel WG, et al. Genpolymorphismus bei der verkalkten Aortenklappenstenose. Herz 2006;31:635-43.
5. Franke A, Kühl HP. Diagnose und Schweregradbeurteilung bei Aortenklappenstenose. Herz 2006;31:644-9.
6. Malyar NM, Schlosser T, Buck T, et al. Using cardiac magnetic resonance tomography for assessment of aortic valve area in aortic valve stenosis. Herz 2006;31:650-7.
7. Weber M, Hamm C. Biomarker zur Abschätzung des Schweregrades der Aortenklappenstenose. Herz 2006;31:658-63.
8. Baumgartner H. Asymptomatische Aortenstenose. Wann soll man operieren? Wann kann man zuwarten? Herz 2006;31:664-9.
9. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290-5.
10. Rosenhek R, Maurer G, Baumgartner H. Should early elective surgery be performed in patients with severe but asymptomatic aortic stenosis? Eur Heart J 2002;23:1417-21.
11. Kleikamp G, Maleszka A, Zittermann A, et al. Standardtherapie der Aortenklappenstenose. Indikation und Ergebnisse. Herz 2006;31:670-5.
12. Wittlinger T, Aybek T, Moritz A, et al. Indikation, Technik und Ergebnisse rekonstruktiver Eingriffe an der Aortenklappe und Aorta ascendens. Herz 2006;31:676-84.
13. Andersen HR, Knudsen LL, Hasemkam JM. Transluminal implantation of artificial heart valves: description of a new expandable aortic valve and initial results with implantation by catheter techniques in closed chest pigs. Eur Heart J 1992;13:704-8.
14. Figulla HR, Ferrari M. Perkutan implantierbare Aortenklappe: die JenaValve-Konzept-Evolution. Herz 2006;31:685-87.
15. Cribier A, Eltchaninoff H, Thron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698-703.
16. Sack S, Naber C, Kahlert P, et al. Percutaneous heart valve implantation in the aortic position. Herz,2005;30:433-7.
17. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-50.
18. Sack S, Kahlert P, Naber C, et al. Aortenklappenstenose: von der Valvuloplastie zum perkutanen Klappenersatz. Herz 2006;31:688-93.
19. Laborde JC, Borenstein N, Behr L, et al. Percutaneous implantation of an aortic valve prosthesis. Cathet Cardiovasc Interv 2005;65:171-4.
20. Grube E, Laborde JC, Zickmann B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Cathet Cardiovasc Interv 2005;66:465-9.
21. Grube E, Gerckens U, Buellesfeld L. Perkutaner Aortenklappenersatz. Herz 2006;31:694-7.
22. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-43.
23. Grüntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979;301:61-8.
24. Dewey TM, Walther T, Doss M, et al. Transapical aortic valve implantation: an animal feasibility study. Ann Thorac Surg 2006;82:110-6.
25. Leyh R, Yildirim C, Buck T, et al. Early single-center experience with the 3F-Enable aortic valve bioprosthesis. Herz 2006;31:423-8.